Stella Diagnostics, Inc. (SLDX)
OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0050 (-14.29%)
At close: Aug 6, 2025
Stella Diagnostics Company Description
Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases.
It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus.
The company’s technology notifies gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for disease progression into precancer or cancer.
The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in April 2021.
Stella Diagnostics, Inc. is headquartered in Salt Lake City, Utah.
Stella Diagnostics, Inc.
| Country | United States |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 2 |
| CEO | David Seaburg |
Contact Details
Address: 50 West Broadway Salt Lake City, Florida 84101 United States | |
| Phone | 201 381 1474 |
| Website | stelladx.com |
Stock Details
| Ticker Symbol | SLDX |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US85853Y1047 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| David B. Seaburg | Chief Executive Officer and Director |